Copia Investment Partners lifts stake in Botanix Pharmaceuticals

Copia Investment Partners Ltd has become a more substantial holder in Botanix Pharmaceuticals Ltd (ASX: BOT), with its voting power rising from 6.23% to 7.28%. This increase represents a change from 122,100,000 votes to 142,700,000 votes. The notice of change was given on November 19, 2025.

The change in relevant interests occurred through a series of transactions in September, October, and November 2025. Key acquisitions include 3,200,000 ordinary shares in September at an average price of $0.163, 16,400,000 ordinary shares in October at an average price of $0.151, and an additional 1,000,000 ordinary shares in November at an average price of $0.129.

After these changes, Copia Investment Partners Ltd holds 104,200,000 ordinary shares through HSBC Custody Nominees (Australia) Limited, and UniSuper Limited holds 38,500,000 ordinary shares through BNP Paribas Fund Services Australasia Pty Ltd, collectively accounting for the increased substantial holding.